Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    February 2017
  1. MILLER JA, Kotecha R, Ahluwalia MS, Mohammadi AM, et al
    Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30616.
    PubMed     Text format     Abstract available


  2. SANDLER KA, Shaverdian N, Cook RR, Kishan AU, et al
    Treatment trends for patients with brain metastases: Does practice reflect the data?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30607.
    PubMed     Text format     Abstract available


    November 2016
  3. DUNN-PIRIO AM, Vlahovic G
    Immunotherapy approaches in the treatment of malignant brain tumors.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30371.
    PubMed     Text format     Abstract available


    October 2016
  4. BOELE FW, Given CW, Given BA, Donovan HS, et al
    Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30428.
    PubMed     Text format     Abstract available



  5. Erratum: Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R and Larocca LM. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer. 2011;117:162-17
    Cancer. 2016;122:3090.
    PubMed     Text format    


    September 2016
  6. CALDARELLA A, Barchielli A
    Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30341.
    PubMed     Text format    


  7. GRAMATZKI D, Weller M
    Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30340.
    PubMed     Text format    


    August 2016
  8. AGBAHIWE H, Rashid A, Horska A, Mahone EM, et al
    A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30313.
    PubMed     Text format     Abstract available


  9. RONG X, Yang W, Garzon-Muvdi T, Caplan JM, et al
    Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
    Cancer. 2016 Aug 8. doi: 10.1002/cncr.30160.
    PubMed     Text format     Abstract available


  10. JHAWAR SR, Kaufman HL, Goyal S
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30244.
    PubMed     Text format    


  11. YU JB, Chiang VL
    Reply to timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Aug 6. doi: 10.1002/cncr.30243.
    PubMed     Text format    


    July 2016
  12. NOOKA AK, Behera M, Lonial S, Dixon MD, et al
    Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
    Cancer. 2016 Jul 12. doi: 10.1002/cncr.30090.
    PubMed     Text format     Abstract available


  13. MILLER JA, Kotecha R, Suh JH
    Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30188.
    PubMed     Text format    


  14. HALASZ LM, Uno H, Punglia RS
    Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Cancer. 2016 Jul 8. doi: 10.1002/cncr.30187.
    PubMed     Text format    


    June 2016
  15. EISELE SC, Reardon DA
    Adult brainstem gliomas.
    Cancer. 2016 Jun 21. doi: 10.1002/cncr.29920.
    PubMed     Text format     Abstract available


  16. QIAN JM, Yu JB, Kluger HM, Chiang VL, et al
    Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Cancer. 2016 Jun 10. doi: 10.1002/cncr.30138.
    PubMed     Text format     Abstract available


  17. DASENBROCK HH, Devine CA, Liu KX, Gormley WB, et al
    Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis.
    Cancer. 2016;122:1708-17.
    PubMed     Text format     Abstract available


    May 2016
  18. MANSOURI A, Mansouri S, Hachem LD, Klironomos G, et al
    The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30088.
    PubMed     Text format     Abstract available


  19. VERMA V, Mishra MV, Mehta MP
    A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Cancer. 2016;122:1483-501.
    PubMed     Text format     Abstract available


  20. KOLE AJ, Park HS, Yeboa DN, Rutter CE, et al
    Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
    Cancer. 2016 May 12. doi: 10.1002/cncr.30063.
    PubMed     Text format     Abstract available


    April 2016
  21. GRAMATZKI D, Dehler S, Rushing EJ, Zaugg K, et al
    Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Apr 18. doi: 10.1002/cncr.30023.
    PubMed     Text format     Abstract available


  22. HALASZ LM, Uno H, Hughes M, D'Amico T, et al
    Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Cancer. 2016 Apr 18. doi: 10.1002/cncr.30009.
    PubMed     Text format     Abstract available


  23. PRINTZ C
    Pediatric gliomas with CRAF fusions may require combination treatment.
    Cancer. 2016;122:1148.
    PubMed     Text format    


  24. GONCALVES PH, Peterson SL, Vigneau FD, Shore RD, et al
    Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
    Cancer. 2016 Apr 8. doi: 10.1002/cncr.30000.
    PubMed     Text format     Abstract available


  25. ATER JL, Xia C, Mazewski CM, Booth TN, et al
    Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Cancer. 2016 Apr 8. doi: 10.1002/cncr.29987.
    PubMed     Text format     Abstract available


    March 2016
  26. ELLINGSON BM, Nguyen HN, Lai A, Nechifor RE, et al
    Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma.
    Cancer. 2016 Mar 21. doi: 10.1002/cncr.29957.
    PubMed     Text format     Abstract available


  27. KRISHNATRY R, Zhukova N, Guerreiro Stucklin AS, Pole JD, et al
    Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Cancer. 2016 Mar 10. doi: 10.1002/cncr.29907.
    PubMed     Text format     Abstract available


  28. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  29. DE BLANK PM, Fisher MJ, Lu L, Leisenring WM, et al
    Impact of vision loss among survivors of childhood central nervous system astroglial tumors.
    Cancer. 2016;122:730-9.
    PubMed     Text format     Abstract available


    February 2016
  30. PRINTZ C
    NCI seeks to speed drug development for pediatric cancers: New initiative aims to help prioritize agents with most potential.
    Cancer. 2016;122:499-500.
    PubMed     Text format    


    December 2015
  31. STEUER CE, Behera M, Berry L, Kim S, et al
    Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29812.
    PubMed     Text format     Abstract available


    November 2015
  32. JORDAN JT, Gerstner ER, Batchelor TT, Cahill DP, et al
    Glioblastoma care in the elderly.
    Cancer. 2015 Nov 30. doi: 10.1002/cncr.29742.
    PubMed     Text format     Abstract available


  33. SCHIFF D, Desjardins A, Cloughesy T, Mikkelsen T, et al
    Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
    Cancer. 2015 Nov 20. doi: 10.1002/cncr.29798.
    PubMed     Text format     Abstract available


  34. LANDSBURG DJ, Petrich AM, Abramson JS, Sohani AR, et al
    Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Cancer. 2015 Nov 13. doi: 10.1002/cncr.29781.
    PubMed     Text format     Abstract available


    September 2015
  35. SAVITZ ST, Chen RC, Sher DJ
    Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases.
    Cancer. 2015 Sep 15. doi: 10.1002/cncr.29642.
    PubMed     Text format     Abstract available


    August 2015
  36. AIZER AA, Bi WL, Kandola MS, Lee EQ, et al
    Extent of resection and overall survival for patients with atypical and malignant meningioma.
    Cancer. 2015 Aug 26. doi: 10.1002/cncr.29639.
    PubMed     Text format     Abstract available


  37. NAYAK L, DeAngelis LM, Robins HI, Govindan R, et al
    Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
    Cancer. 2015 Aug 26. doi: 10.1002/cncr.29636.
    PubMed     Text format     Abstract available


  38. BRINKMAN TM, Bass JK, Li Z, Ness KK, et al
    Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.
    Cancer. 2015 Aug 19. doi: 10.1002/cncr.29604.
    PubMed     Text format     Abstract available


  39. DODGSHUN AJ, Elder JE, Hansford JR, Sullivan MJ, et al
    Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Cancer. 2015 Aug 17. doi: 10.1002/cncr.29649.
    PubMed     Text format     Abstract available


  40. PRESS RH, Prabhu RS, Nickleach DC, Liu Y, et al
    Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
    Cancer. 2015 Aug 4. doi: 10.1002/cncr.29590.
    PubMed     Text format     Abstract available


    May 2015
  41. KIM YH, Kim T, Joo JD, Han JH, et al
    Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
    Cancer. 2015 May 14. doi: 10.1002/cncr.29439.
    PubMed     Text format     Abstract available


  42. LEVINE DR, Johnson LM, Mandrell BN, Yang J, et al
    Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer.
    Cancer. 2015;121:1508-12.
    PubMed     Text format     Abstract available


    April 2015
  43. DOLECEK TA, Dressler EV, Thakkar JP, Liu M, et al
    Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.
    Cancer. 2015 Apr 14. doi: 10.1002/cncr.29379.
    PubMed     Text format     Abstract available


  44. PRINTZ C
    Electrical device for patients with glioblastoma met with support, skepticism: Some question the device's efficacy, others tout it as a new standard of care.
    Cancer. 2015;121:969-70.
    PubMed     Text format    


    March 2015
  45. GERSTENECKER A, Meneses K, Duff K, Fiveash JB, et al
    Cognitive predictors of understanding treatment decisions in patients with newly diagnosed brain metastasis.
    Cancer. 2015 Mar 3. doi: 10.1002/cncr.29326.
    PubMed     Text format     Abstract available


  46. PRINTZ C
    Death with dignity: Young patient with brain tumor puts a face on the right-to-die movement.
    Cancer. 2015;121:641-3.
    PubMed     Text format    


  47. BARTLETT EK, Simmons KD, Wachtel H, Roses RE, et al
    The rise in metastasectomy across cancer types over the past decade.
    Cancer. 2015;121:747-57.
    PubMed     Text format     Abstract available


    January 2015
  48. LI AM, Dunham C, Tabori U, Carret AS, et al
    EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study.
    Cancer. 2015 Jan 13. doi: 10.1002/cncr.29198.
    PubMed     Text format     Abstract available


  49. SHIH HA, Sherman JC, Nachtigall LB, Colvin MK, et al
    Proton therapy for low-grade gliomas: Results from a prospective trial.
    Cancer. 2015 Jan 13. doi: 10.1002/cncr.29237.
    PubMed     Text format     Abstract available


  50. GITTLEMAN HR, Ostrom QT, Rouse CD, Dowling JA, et al
    Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.
    Cancer. 2015;121:102-12.
    PubMed     Text format     Abstract available


    December 2014
  51. ZHONG J, Ali AN, Voloschin AD, Liu Y, et al
    Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
    Cancer. 2014 Dec 29. doi: 10.1002/cncr.29234.
    PubMed     Text format     Abstract available


  52. YAEGER R, Cowell E, Chou JF, Gewirtz AN, et al
    RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer.
    Cancer. 2014 Dec 9. doi: 10.1002/cncr.29196.
    PubMed     Text format     Abstract available


    September 2014
  53. CHEN YB, Batchelor T, Li S, Hochberg E, et al
    Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma
    Cancer. 2014 Sep 9. doi: 10.1002/cncr.29023.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: